← Back
Data updated: Nov 8, 2026
EVEREST LIFESCIENCES
Generics Pharmaceuticals
EVEREST LIFESCIENCES is a generic drug manufacturer with 3 FDA-approved products.
2015
Since
3
Drugs
-
Trials
1
New Drugs (2yr)
EVEREST LIFESCIENCES's Key Drugs
EVEREST LIFESCIENCES's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
EVEREST LIFESCIENCES's Recent FDA Approvals
EVEREST LIFESCIENCES secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
EVEREST LIFESCIENCES's Therapeutic Areas
Disease areas where EVEREST LIFESCIENCES has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
EVEREST LIFESCIENCES Pipeline Snapshot
Active clinical trials for EVEREST LIFESCIENCES across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2015-10-28
- Latest
- 2021-10-25
- Applications
- 3